Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00432-014-1766-4.

Title:
TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer | Journal of Cancer Research and Clinical Oncology
Description:
Hypermethylation of TFAP2E (AP-2E) is associated with the chemotherapy-resistant in patients with colorectal cancer (CRC), but its implications on prognosis directly remain unknown. This study was aimed to investigate the role of AP-2E methylation status and other clinicopathologic parameters as predictors of prognosis. We detected the methylation status of AP-2E in tumor and adjacent non-tumor tissues from 311 sporadic CRC patients by methylation-sensitive high-resolution melting analysis. Log-rank tests and multivariate Cox analyses were performed to evaluate the role of AP-2E methylation status and other clinicopathologic parameters as predictors of prognosis. Hypermethylation of AP-2E was detected in 61 % (190/311) tumor tissues. It occurred more frequently in tumors in earlier stages (I/II; P = 0.02), lower levels of tumor invasion (T1–T3; P = 0.04), fewer lymph nodes involved (N0; P < 0.01), and higher histologic grades (G1/G2; P < 0.01). The overall 5-year survival rates in hypermethylation and hypomethylation group were 76.91 and 47.17 % (P < 0.0001), respectively. AP-2E hypermethylation was significantly associated with a favorable clinical outcome with a hazard ratio of 0.486 (95 % CI 0.342–0.692, P < 0.0001) after controlling for age, gender, tumor location, histologic type, TNM staging, and histologic grade. AP-2E was frequently hypermethylated in tumors from patients with CRC. Aberrant hypermethylation of AP-2E occurred more frequently in tumors with earlier stages, lower levels of tumor invasion, fewer lymph nodes involved, and higher histologic grades. AP-2E hypermethylation might be an independent predictor of survival advantage in patients with CRC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We don’t know how the website earns money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {šŸ”}

cancer, pubmed, article, google, scholar, cas, colorectal, methylation, central, hypermethylation, survival, ape, patients, dna, wang, tumor, transcription, zhang, access, gene, privacy, cookies, content, journal, research, clinical, zhao, prognosis, breast, expression, oncol, publish, search, tfape, xia, lin, yashuang, crc, status, histologic, factor, cell, chen, resistance, mol, china, harbin, data, information, log,

Topics {āœ’ļø}

methylation-sensitive high-resolution melting month download article/chapter transcription factor ap-2alpha ya-shuang zhao large population-based sample methylation-induced repression–belts egfr-targeted monoclonal antibodies bin-bin cui ap-2e methylation status related subjects full article pdf dna methylation biomarkers aberrant dna methylation mouse skin cancers clinical oncology aims unbiased methylation profiling privacy choices/manage cookies breast cancer cells ap-2 transcription factors colorectal cancers advanced bladder cancer genome-wide screening epithelial ovarian cancer global cancer statistics nhs cancer plan favorable clinical outcome dna methylation lymph node metastasis gastric adenocarcinoma prognosis genomic biomarker discovery p53 mutation status cell-cycle control conclusions ap-2e ap-2e hypermethylation european economic area fu-lan hu multivariate cox analyses 5-year survival rates reinacher-schick ac chronic myelogenous leukemia sartore-bianchi brca1 interactor srbc article zhang hmlh1 promoter hypermethylation article log prostate cancer cells conditions privacy policy colorectal cancer breast cancer breast cancer

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer
         description:Hypermethylation of TFAP2E (AP-2E) is associated with the chemotherapy-resistant in patients with colorectal cancer (CRC), but its implications on prognosis directly remain unknown. This study was aimed to investigate the role of AP-2E methylation status and other clinicopathologic parameters as predictors of prognosis. We detected the methylation status of AP-2E in tumor and adjacent non-tumor tissues from 311 sporadic CRC patients by methylation-sensitive high-resolution melting analysis. Log-rank tests and multivariate Cox analyses were performed to evaluate the role of AP-2E methylation status and other clinicopathologic parameters as predictors of prognosis. Hypermethylation of AP-2E was detected in 61Ā % (190/311) tumor tissues. It occurred more frequently in tumors in earlier stages (I/II; PĀ =Ā 0.02), lower levels of tumor invasion (T1–T3; PĀ =Ā 0.04), fewer lymph nodes involved (N0; PĀ <Ā 0.01), and higher histologic grades (G1/G2; PĀ <Ā 0.01). The overall 5-year survival rates in hypermethylation and hypomethylation group were 76.91 and 47.17Ā % (PĀ <Ā 0.0001), respectively. AP-2E hypermethylation was significantly associated with a favorable clinical outcome with a hazard ratio of 0.486 (95Ā % CI 0.342–0.692, PĀ <Ā 0.0001) after controlling for age, gender, tumor location, histologic type, TNM staging, and histologic grade. AP-2E was frequently hypermethylated in tumors from patients with CRC. Aberrant hypermethylation of AP-2E occurred more frequently in tumors with earlier stages, lower levels of tumor invasion, fewer lymph nodes involved, and higher histologic grades. AP-2E hypermethylation might be an independent predictor of survival advantage in patients with CRC.
         datePublished:2014-07-06T00:00:00Z
         dateModified:2014-07-06T00:00:00Z
         pageStart:2119
         pageEnd:2127
         sameAs:https://doi.org/10.1007/s00432-014-1766-4
         keywords:
            Colorectal cancer
            TFAP2E
            DNA methylation
            Prognosis
            Oncology
            Cancer Research
            Internal Medicine
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-014-1766-4/MediaObjects/432_2014_1766_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-014-1766-4/MediaObjects/432_2014_1766_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-014-1766-4/MediaObjects/432_2014_1766_Fig3_HTML.gif
         isPartOf:
            name:Journal of Cancer Research and Clinical Oncology
            issn:
               1432-1335
               0171-5216
            volumeNumber:140
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zuo-Ming Zhang
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yibaina Wang
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rong Huang
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu-Peng Liu
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xia Li
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fu-Lan Hu
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lin Zhu
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fan Wang
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bin-Bin Cui
               affiliation:
                     name:Cancer Hospital of Harbin Medical University
                     address:
                        name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin-Shu Dong
               affiliation:
                     name:Cancer Hospital of Harbin Medical University
                     address:
                        name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ya-Shuang Zhao
               affiliation:
                     name:Harbin Medical University
                     address:
                        name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer
      description:Hypermethylation of TFAP2E (AP-2E) is associated with the chemotherapy-resistant in patients with colorectal cancer (CRC), but its implications on prognosis directly remain unknown. This study was aimed to investigate the role of AP-2E methylation status and other clinicopathologic parameters as predictors of prognosis. We detected the methylation status of AP-2E in tumor and adjacent non-tumor tissues from 311 sporadic CRC patients by methylation-sensitive high-resolution melting analysis. Log-rank tests and multivariate Cox analyses were performed to evaluate the role of AP-2E methylation status and other clinicopathologic parameters as predictors of prognosis. Hypermethylation of AP-2E was detected in 61Ā % (190/311) tumor tissues. It occurred more frequently in tumors in earlier stages (I/II; PĀ =Ā 0.02), lower levels of tumor invasion (T1–T3; PĀ =Ā 0.04), fewer lymph nodes involved (N0; PĀ <Ā 0.01), and higher histologic grades (G1/G2; PĀ <Ā 0.01). The overall 5-year survival rates in hypermethylation and hypomethylation group were 76.91 and 47.17Ā % (PĀ <Ā 0.0001), respectively. AP-2E hypermethylation was significantly associated with a favorable clinical outcome with a hazard ratio of 0.486 (95Ā % CI 0.342–0.692, PĀ <Ā 0.0001) after controlling for age, gender, tumor location, histologic type, TNM staging, and histologic grade. AP-2E was frequently hypermethylated in tumors from patients with CRC. Aberrant hypermethylation of AP-2E occurred more frequently in tumors with earlier stages, lower levels of tumor invasion, fewer lymph nodes involved, and higher histologic grades. AP-2E hypermethylation might be an independent predictor of survival advantage in patients with CRC.
      datePublished:2014-07-06T00:00:00Z
      dateModified:2014-07-06T00:00:00Z
      pageStart:2119
      pageEnd:2127
      sameAs:https://doi.org/10.1007/s00432-014-1766-4
      keywords:
         Colorectal cancer
         TFAP2E
         DNA methylation
         Prognosis
         Oncology
         Cancer Research
         Internal Medicine
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-014-1766-4/MediaObjects/432_2014_1766_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-014-1766-4/MediaObjects/432_2014_1766_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-014-1766-4/MediaObjects/432_2014_1766_Fig3_HTML.gif
      isPartOf:
         name:Journal of Cancer Research and Clinical Oncology
         issn:
            1432-1335
            0171-5216
         volumeNumber:140
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zuo-Ming Zhang
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yibaina Wang
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rong Huang
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu-Peng Liu
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xia Li
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fu-Lan Hu
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lin Zhu
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fan Wang
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bin-Bin Cui
            affiliation:
                  name:Cancer Hospital of Harbin Medical University
                  address:
                     name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin-Shu Dong
            affiliation:
                  name:Cancer Hospital of Harbin Medical University
                  address:
                     name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ya-Shuang Zhao
            affiliation:
                  name:Harbin Medical University
                  address:
                     name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Cancer Research and Clinical Oncology
      issn:
         1432-1335
         0171-5216
      volumeNumber:140
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Cancer Hospital of Harbin Medical University
      address:
         name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Cancer Hospital of Harbin Medical University
      address:
         name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
      name:Harbin Medical University
      address:
         name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zuo-Ming Zhang
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yibaina Wang
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Rong Huang
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yu-Peng Liu
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xia Li
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Fu-Lan Hu
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Lin Zhu
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Fan Wang
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Bin-Bin Cui
      affiliation:
            name:Cancer Hospital of Harbin Medical University
            address:
               name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xin-Shu Dong
      affiliation:
            name:Cancer Hospital of Harbin Medical University
            address:
               name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Ya-Shuang Zhao
      affiliation:
            name:Harbin Medical University
            address:
               name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
      name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
      name:Cancer Hospital of Harbin Medical University, Harbin, People’s Republic of China
      name:Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, People’s Republic of China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(174)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {šŸ“¦}

  • Crossref

3.85s.